119.00
-2.00
(-1.65%)
As of 8:01:28 AM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 6 | 14 | 14 |
| Avg. Estimate | 110.99M | 94.19M | 313.61M | 541.95M |
| Low Estimate | 71.57M | 77.1M | 261.3M | 439M |
| High Estimate | 178.39M | 109.6M | 410.44M | 749M |
| Year Ago Sales | 137.7M | 95.89M | 266.72M | 313.61M |
| Sales Growth (year/est) | -19.40% | -1.78% | 17.58% | 72.81% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| A71.F | -- | -- | -- | -- |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Upgrades & Downgrades
| Initiated | UBS: Buy | 1/7/2025 |
| Maintains | TD Cowen: Buy to Buy | 11/15/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 11/15/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 11/15/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 11/15/2024 |
| Maintains | Stifel: Buy to Buy | 11/15/2024 |
Related Tickers
83B.F 3SBio Inc.
0.7500
+1.35%
RV7.F Halozyme Therapeutics, Inc.
52.64
-0.64%
TRSBF 3SBio Inc.
0.8279
0.00%
2CL.BE BridgeBio Pharma Inc
34.63
-1.20%
1530.HK 3SBIO
6.210
+1.14%
ARGX argenx SE
648.94
-0.50%
IPA ImmunoPrecise Antibodies Ltd.
0.5765
-3.92%
VKTX Viking Therapeutics, Inc.
34.50
-1.26%
RXRX Recursion Pharmaceuticals, Inc.
7.33
-2.66%